1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research
Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive
Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice
of Customer
5. Clinical
Trial Analysis
5.1. Ongoing
Clinical Trials
5.2. Completed
Clinical Trials
5.3. Terminated
Clinical Trials
5.4. Breakdown
of Pipeline, By Development Phase
5.5. Breakdown
of Pipeline, By Status
5.6. Breakdown
of Pipeline, By Study Type
5.7. Breakdown
of Pipeline, By Region
5.8. Clinical
Trials Heat Map
6.
Global Dry Eye Syndrome Treatment
Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1.
By Indication (Evaporative Dry Eye Syndrome
v/s Aqueous Deficient Dry Eye Syndrome)
6.2.2.
By Product Type (Cyclosporine, Topical
Corticosteroids, Artificial Tears, Punctal Plugs, Others)
6.2.3.
By Dosage Form (Gels, Eye Solutions, Capsules
& Tablets, Eye Drops, Ointments)
6.2.4.
By Type (Prescription v/s Over The Counter)
6.2.5.
By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online Pharmacies)
6.2.6.
By Region
6.2.7. By
Company (2022)
6.3. Market
Map
6.3.1. By
Indication
6.3.2. By
Product Type
6.3.3. By
Dosage Form
6.3.4. By
Type
6.3.5. By
Distribution Channel
6.3.6. By
Region
7.
North America Dry Eye Syndrome Treatment
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By Indication
7.2.2.
By Product Type
7.2.3.
By Dosage Form
7.2.4.
By Type
7.2.5.
By Distribution Channel
7.2.6. By
Country
7.3. North
America: Country Analysis
7.3.1. United
States Dry Eye Syndrome Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Indication
7.3.1.2.2.
By Product Type
7.3.1.2.3.
By Dosage Form
7.3.1.2.4.
By Type
7.3.1.2.5.
By Distribution Channel
7.3.2. Canada
Dry Eye Syndrome Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Indication
7.3.2.2.2.
By Product Type
7.3.2.2.3.
By Dosage Form
7.3.2.2.4.
By Type
7.3.2.2.5.
By Distribution Channel
7.3.3. Mexico
Dry Eye Syndrome Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Indication
7.3.3.2.2.
By Product Type
7.3.3.2.3.
By Dosage Form
7.3.3.2.4.
By Type
7.3.3.2.5.
By Distribution Channel
8.
Europe Dry Eye Syndrome Treatment
Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By Indication
8.2.2.
By Product Type
8.2.3.
By Dosage Form
8.2.4.
By Type
8.2.5.
By Distribution Channel
8.2.6.
By Country
8.3. Europe:
Country Analysis
8.3.1. France
Dry Eye Syndrome Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Indication
8.3.1.2.2.
By Product Type
8.3.1.2.3.
By Dosage Form
8.3.1.2.4.
By Type
8.3.1.2.5.
By Distribution Channel
8.3.2. Germany
Dry Eye Syndrome Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Indication
8.3.2.2.2.
By Product Type
8.3.2.2.3.
By Dosage Form
8.3.2.2.4.
By Type
8.3.2.2.5.
By Distribution Channel
8.3.3. United
Kingdom Dry Eye Syndrome Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Indication
8.3.3.2.2.
By Product Type
8.3.3.2.3.
By Dosage Form
8.3.3.2.4.
By Type
8.3.3.2.5.
By Distribution Channel
8.3.4. Italy
Dry Eye Syndrome Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Indication
8.3.4.2.2.
By Product Type
8.3.4.2.3.
By Dosage Form
8.3.4.2.4.
By Type
8.3.4.2.5.
By Distribution Channel
8.3.5. Spain
Dry Eye Syndrome Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Indication
8.3.5.2.2.
By Product Type
8.3.5.2.3.
By Dosage Form
8.3.5.2.4.
By Type
8.3.5.2.5.
By Distribution Channel
9.
Asia-Pacific Dry Eye Syndrome Treatment
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By Indication
9.2.2.
By Product Type
9.2.3.
By Dosage Form
9.2.4.
By Type
9.2.5.
By Distribution Channel
9.2.6. By
Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China
Dry Eye Syndrome Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Indication
9.3.1.2.2.
By Product Type
9.3.1.2.3.
By Dosage Form
9.3.1.2.4.
By Type
9.3.1.2.5.
By Distribution Channel
9.3.2. India
Dry Eye Syndrome Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Indication
9.3.2.2.2.
By Product Type
9.3.2.2.3.
By Dosage Form
9.3.2.2.4.
By Type
9.3.2.2.5.
By Distribution Channel
9.3.3. Japan
Dry Eye Syndrome Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Indication
9.3.3.2.2.
By Product Type
9.3.3.2.3.
By Dosage Form
9.3.3.2.4.
By Type
9.3.3.2.5.
By Distribution Channel
9.3.4. South
Korea Dry Eye Syndrome Treatment Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Indication
9.3.4.2.2.
By Product Type
9.3.4.2.3.
By Dosage Form
9.3.4.2.4.
By Type
9.3.4.2.5.
By Distribution Channel
9.3.5. Australia
Dry Eye Syndrome Treatment Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Indication
9.3.5.2.2.
By Product Type
9.3.5.2.3.
By Dosage Form
9.3.5.2.4.
By Type
9.3.5.2.5.
By Distribution Channel
10. South
America Dry Eye Syndrome Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By Indication
10.2.2.
By Product Type
10.2.3.
By Dosage Form
10.2.4.
By Type
10.2.5.
By Distribution Channel
10.2.6. By
Country
10.3.
South America: Country Analysis
10.3.1. Brazil
Dry Eye Syndrome Treatment Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Indication
10.3.1.2.2.
By Product Type
10.3.1.2.3.
By Dosage Form
10.3.1.2.4.
By Type
10.3.1.2.5.
By Distribution Channel
10.3.2. Argentina
Dry Eye Syndrome Treatment Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Indication
10.3.2.2.2.
By Product Type
10.3.2.2.3.
By Dosage Form
10.3.2.2.4.
By Type
10.3.2.2.5.
By Distribution Channel
10.3.3. Colombia
Dry Eye Syndrome Treatment Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Indication
10.3.3.2.2.
By Product Type
10.3.3.2.3.
By Dosage Form
10.3.3.2.4.
By Type
10.3.3.2.5.
By Distribution Channel
11. Middle
East and Africa Dry Eye Syndrome Treatment Market Outlook
11.1.
Market Size & Forecast
11.1.1. By
Value
11.2.
Market Share & Forecast
11.2.1.
By Indication
11.2.2.
By Product Type
11.2.3.
By Dosage Form
11.2.4.
By Type
11.2.5.
By Distribution Channel
11.2.6. By
Country
11.3.
MEA: Country Analysis
11.3.1. South
Africa Dry Eye Syndrome Treatment Market Outlook
11.3.1.1. Market
Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market
Share & Forecast
11.3.1.2.1.
By Indication
11.3.1.2.2.
By Product Type
11.3.1.2.3.
By Dosage Form
11.3.1.2.4.
By Type
11.3.1.2.5.
By Distribution Channel
11.3.2. Saudi
Arabia Dry Eye Syndrome Treatment Market Outlook
11.3.2.1. Market
Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market
Share & Forecast
11.3.2.2.1.
By Indication
11.3.2.2.2.
By Product Type
11.3.2.2.3.
By Dosage Form
11.3.2.2.4.
By Type
11.3.2.2.5.
By Distribution Channel
11.3.3. UAE
Dry Eye Syndrome Treatment Market Outlook
11.3.3.1. Market
Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market
Share & Forecast
11.3.3.2.1.
By Indication
11.3.3.2.2.
By Product Type
11.3.3.2.3.
By Dosage Form
11.3.3.2.4.
By Type
11.3.3.2.5.
By Distribution Channel
12. Market
Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market
Trends & Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Launches
14. Competitive
Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1.
Johnson
& Johnson
14.6.2.
AbbVie
Inc.
14.6.3.
Bausch
Health Companies Inc.
14.6.4.
Novartis
AG
14.6.5.
Sun
Pharmaceuticals Industries Limited
14.6.6.
Santen
Pharmaceutical Co., Ltd.
14.6.7.
Otsuka
Pharmaceutical Co., Ltd.
14.6.8.
Oyster
Point Pharma, Inc.
14.6.9.
Alcon
Inc.
14.6.10.
GlaxoSmithKline
plc.
Strategic
Recommendations